3D Systems Corporation · NYSE:DDD

3D Systems — Investor Presentation (June 2021)

38 slides from 3D Systems's investor presentation, June 2021

  1. Slide 1: Investor Presentation

    Investor Presentation June 2021 ©2021 3D Systems, Inc. | All Rights Reserved.

  2. Slide 2: Safe Harbor

    Safe Harbor Certain statements made in this presentation that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals

  3. Slide 3: Key Messages

    Key Messages New management team executing A leader in a large growth market Full Solution capabilities with focus a transformation journey on application driven growth 3

  4. Slide 4: New Leader. New Future.

    New Leader. New Future. Dr. Jeffrey Graves is President and CEO of 3D Systems and joined the company on May 26, 2020. Prior to joining 3D Systems, from 2012 to May 2020, he served as CEO, President and Director of MTS Systems Corporation, a global supplier of test, simulation, and measurement system

  5. Slide 5: Purpose Statement

    Purpose Statement We are the leaders in enabling additive manufacturing solutions for applications in growing markets that demand high reliability products. 5

  6. Slide 6: Transformation is Yielding Results

    Transformation is Yielding Results Strategic Reorganize Restructure Divest/Invest Purpose Focus on operational execution Intentional action on our 4-stage plan 6

  7. Slide 7: Why Additive Manufacturing (AM)? Tangible Benefits to AM Design

    Why Additive Manufacturing (AM)? Tangible Benefits to AM Design Capability for Mass Improved Lead Part / Assembly Customization Times Consolidation Supply Chain Precision Weight Optimization and Parts Reduction Flexibility 7

  8. Slide 8: Market Opportunity: 3D Printing Market Forecast

    Market Opportunity: 3D Printing Market Forecast AM Growth Estimate $40 $37.2 SCALE OF AM GROWTH $30.9 Over the next 3 years, market is $30 expected to grow on average at 17% $24.9 CAGR, reaching $37B in 2026 USD (in Billions) $20.2 $20 $17.4 INDUSTRY GROWTH DRIVERS $15.0 High focus to introduce new

  9. Slide 9: 3D Systems Is A Full Solution Provider

    3D Systems Is A Full Solution Provider Services and Software Hardware and Materials Application experts & Customer Full range of 3D printers to address Innovation Centers AM needs in metals, plastics and wax Printing process and management Professional and production systems software tools 100+ Mate

  10. Slide 10: AM Solutions Tailored to Applications That Demand High Reliability

    AM Solutions Tailored to Dental Semiconductor Applications That Demand Simulations Automotive High Reliability Solutions Experts Medical Aerospace & Backed by an organizational Device Application Engineers Defense commitment to engineering Customer Success excellence Surgical Jewelry Planning Biopri

  11. Slide 11: Develop, Validate, and Commercialize

    Develop, Advanced manufacturing facilities at our Customer Innovation Centers in South Carolina, Colorado, Validate, and California, Belgium, and Germany. Commercialize • Support for design validation, testing/certification, Faster and low volume/batch manufacturing • 150+ machines • 24/7/365 produc

  12. Slide 12: We Shape the Future of Additive Manufacturing

    We Shape the Future of Additive Manufacturing With more AM solutions than anyone in the industry Pioneer digital First scalable regenerative dentistry production platform medicine 1K+ Develop leading Breakthrough world’s largest, software polymer fastest metal 3D printer 12 ©2021 3D Systems, Inc. |

  13. Slide 13: Veterans Health Administration (VHA)

    Healthcare Case Study Veterans Health VA Objectives • COVID-19 related manufacturing Administration (VHA) • Establish quality management system • Develop patient-matched medical device products • Regulatory compliance 3D Systems Solution 3D Systems will assist the VA with • Hardware / materials esta

  14. Slide 14: Orthopedic

    Healthcare Case Study Orthopedic Customer Challenge Machining-plus-coating traditional design and manufacturing Utilized holistic solutions approach processes lead to poor surface quality, high component to develop and commercialize the variability, long process cycle times, high inventory and waste

  15. Slide 15: Investment Casting

    Industrial Case Study Investment Casting Customer Challenge Traditional investment casting production methodology Utilized holistic solutions with limits geometric design options and involves long, materials, hardware and software complex manufacturing cycle times. elements tuned by application expe

  16. Slide 16: Entering the "Invest" Stage of Transformation

    Entering the “Invest” Stage of Transformation Strategic Reorganize Restructure Divest/Invest Purpose 16

  17. Slide 17: Colorado Expansion

    Colorado Expansion • Established operation for groundbreaking precision healthcare applications and medical technology • New investments in application expertise, hardware and software technology will enable us to accelerate time-to-market, expand our offerings, and better support the needs of our g

  18. Slide 18: "Roadrunner" High Speed Fusion

    “Roadrunner” High Speed Fusion Industry Challenges Address demanding aerospace and advanced Specific Applications automotive applications with size, speed and – Direct Printing: aerospace interiors precision that exceeds current market offerings. and ducting, drone components, automotive under dash

  19. Slide 19: Regenerative Medicine

    Regenerative Medicine Industry Challenges Through bioprinting, we have an Demonstrate the capability to print complex thin- opportunity to address patient needs walled structured using biocompatible materials for for organs and soft tissue development applications such as tissue-on-a-chip, using Add

  20. Slide 20: Acquisition: Allevi

    Acquisition: Allevi • Developer of bioprinting solutions: bioprinters, biomaterials / bioinks, and specialized laboratory software • Established presence in over 380 medical and pharmaceutical laboratories in over 40 countries • Positions us to leverage the technology we have developed for in vivo a

  21. Slide 21: Acquisition: Additive Works

    Acquisition: Additive Works • Software company focused on optimization and automation of AM print set-up and workflow generation • Highly automated simulation software interfaces seamlessly with leading CAD systems as well as our 3DXpert and other print platforms • Increases productivity by reducing

  22. Slide 22: Financial Highlights

    Financial Highlights ©2021 3D Systems, Inc. 22 | All Rights Reserved.

  23. Slide 23: Q1 Summary

    Q1 Summary QUARTER ENDED MARCH 31, 2021 2020 HIGHLIGHTS (IN MILLIONS, EXCEPT PER SHARE AMOUNTS) Q1 Revenue increased 7.7% YoY; 16.6% REVENUE $ 146.1 $ 135.6 excluding divested OPERATING LOSS $ (2.0) $ (18.2) business NET INCOME (LOSS) $ 45.2 $ (18.9) INCOME (LOSS) PER SHARE - DILUTED $ 0.36 $ (0.17)

  24. Slide 24: Revenue by Market

    Revenue by Market $ in millions Healthcare Revenue Q1 YoY Industrial Revenue Q1 YoY (excluding divested business) $72.5 +0.7% $73.6 $73.1 +38.7% $52.3 Q1 2020 Q1 2021 Q1 2020 Q1 2021 24 ©2021 3D Systems, Inc. | All Rights Reserved.

  25. Slide 25: Gross Profit Margin

    Gross Profit Margin • Year-over-Year improvement driven by higher sales volume, mix including software sales and the impact of our cost reduction activities • Grew margins despite divesting Cimatron software business 50% 50% GAAP GPM Non-GAAP GPM 45% 44% 45% 44% 43% 43% 43% 43% 42% 42% 41% 40% 40% 3

  26. Slide 26: Operating Expenses

    Operating Expenses GAAP operating expenses decreased 12.1% compared to first quarter 2020 due to savings achieved from cost restructuring activities and the impact of divested businesses offset by higher stock compensation expense Non-GAAP operating expenses decreased 18.7% compared to the prior yea

  27. Slide 27: Adjusted EBITDA Margin

    Adjusted EBITDA Margin Defined as non-GAAP Operating Income plus Depreciation 15.0% 13.6% 13.3% 10.0% 5.3% 5.0% 1.6% 0.0% -3.2% -5.0% Q1 2020 Q2 2020 Q3 2020 Q4 2020 Q1 2021 See appendix for a reconciliation of Non-GAAP Operating Income and Adjusted EBITDA. 27 ©2021 3D Systems, Inc. | All Rights Res

  28. Slide 28: Strong Balance Sheet and Cash Generation

    Strong Balance Sheet and Cash Generation • Generated $28.5 million of cash from operations • Repaid $21.4 million of debt; debt free • $133.0 million of cash, cash equivalents, and restricted cash • $100.0 million undrawn revolver with approximately $92.0 million of availability 28 ©2021 3D Systems,

  29. Slide 29: Trending Up: Growing Profitably and Generating Cash

    Trending Up Growing Profitably and Generating Cash YoY Revenue Growth Rates Cash From Operations 20% $35 10% $25 USD in Millions 0% $15 Q1:20 Q2:20 Q3:20 Q4:20 Q1:21 -10% $5 -20% -$5 Q1:20 Q2:20 Q3:20 Q4:20 Q1:21 -30% -$15 -40% -$25 29 ©2021 3D Systems, Inc. | All Rights Reserved.

  30. Slide 30: Summary

    Summary Focus on operational execution • Return to year-over-year growth • Strong balance sheet and cash generation Intentional action on our 4-stage plan • Exploring additional divestitures of non- core assets • Investing for sustained growth and profitability 30 ©2021 3D Systems, Inc. | All Rights

  31. Slide 31: Thank You

    Thank You Find out more at: www.3dsystems.com 3 31 1 ©2019 3D Systems, Inc. | All Rights Reserved.

  32. Slide 32: Appendix

    Appendix ©2021 3D Systems, Inc. | All Rights Reserved.

  33. Slide 33: Presentation of Information

    Presentation of Information 3D Systems reports is financial results in accordance with GAAP. To facilitate a better understanding of the impact that strategic acquisitions, non-recurring charges and certain non-cash expenses had on its financial results, management reviews certain non-GAAP measures,

  34. Slide 34: Non-GAAP Reconciliation - Operating Income (Loss) (Unaudited)

    Non-GAAP Reconciliation - Operating Income (Loss) (Unaudited) First Quarter Non-GAAP Operating Income (Loss) Quarter Ended March 31, (in millions) 2021 2020 GAAP Operating loss $ (2.0) $ (18.2) Adjustments: Amortization, stock-based compensation & other (1) 13.4 10.7 Legal, acquisition and divestitu

  35. Slide 35: Non-GAAP Reconciliation - Net Income (Loss) (Unaudited)

    Non-GAAP Reconciliation - Net Income (Loss) (Unaudited) First Quarter Non-GAAP Net Income (Loss) Quarter Ended March 31, (in millions) 2021 2020 GAAP Net income (loss) $ 45.2 $ (18.9) Adjustments: Amortization, stock-based compensation & other 13.4 10.7 Legal, acquisition and divestiture related (1)

  36. Slide 36: Non-GAAP Reconciliation - EPS (Unaudited)

    Non-GAAP Reconciliation - EPS (Unaudited) First Quarter Non-GAAP Net Income (Loss) per Share Quarter Ended March 31, 2021 2020 GAAP Net income (loss) per share - basic $ 0.37 $ (0.17) GAAP Net income (loss) per share - diluted $ 0.36 $ (0.17) Adjustments: Amortization, stock-based compensation & oth

  37. Slide 37: Non-GAAP Reconciliation - GP and GPM (Unaudited)

    Non-GAAP Reconciliation - GP and GPM (Unaudited) Quarterly 2020 and 2021 Non-GAAP Gross Profit & Margin 2021 2020 Quarter Ended Quarter Ended (in millions) March 31 March 31 GAAP Gross Profit $ 64.2 $ 57.1 GAAP Gross Profit Margin 44.0 % 42.1 % Adjustments: Amortization, stock-based compensation & o

  38. Slide 38: Non-GAAP Reconciliation - Operating Expense (Unaudited)

    Non-GAAP Reconciliation - Operating Expense (Unaudited) Quarterly 2020 and 2021 Non-GAAP Operating Expenses 2021 2020 Quarter Ended Quarter Ended (in millions) Mar 31 Mar 31 GAAP SG&A Expenses $ 49.6 $ 56.1 GAAP R&D Expenses 16.6 19.2 GAAP Operating Expenses 66.2 75.4 Adjustments to R&D Expenses: Co

3D Systems — Investor Presentation (June 2021) on 6ix